Testing effectiveness (Phase 2)Study completedNCT03463681
What this trial is testing
CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma
Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49